ConductScience.org, home

Paper12395331

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.

Hassan MM and 7 others. Hepatology, 2002. Cited by 588 papers, by iCite.

Cite this record

ConductScience Library. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Papers, record 12395331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12395331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.
PubMed
Journal
Hepatology
PubMed
Year
2002
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
588
iCite
Relative citation ratio, by iCite
13.1
iCite
Revised in PubMed
2022-04-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hassan MMManal M
2Hwang LYLu-Yu
3Hatten CJChiq J
4Swaim MMark
5Li DDonghui
6Abbruzzese JLJames L
7Beasley PPalmer
8Patt YZYehuda Z

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alcohol DrinkingMajor topic
Carcinoma, HepatocellularMajor topic
Diabetes Mellitus, Type 1Major topic
Diabetes Mellitus, Type 2Major topic
Hepatitis BMajor topic
Hepatitis CMajor topic
Liver NeoplasmsMajor topic
Aged
Female
Humans
Male
Middle Aged
Multivariate Analysis
Prevalence
Risk Factors

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in12395312Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology.https://conductscience.org/library/papers/12395312

Source PubMed

Download CSV of comments and corrections

Cited by290

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 588 citations.

PMIDTitleJournalYearIn PapersSource
42860761Missed Diagnosis in Alcohol-Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection.Liver Int2026https://conductscience.org/library/papers/42860761PubMed
42615769Prevention, surveillance, and early detection of hepatocellular carcinoma - a Brazilian multidisciplinary consensus.Arq Bras Cir Dig2026https://conductscience.org/library/papers/42615769PubMed
42569746The Regeneration Paradox in Liver Cancer: How Chronic Injury Transforms Healing into Carcinogenesis.Liver Cancer2026https://conductscience.org/library/papers/42569746PubMed
42168268Global changes in gene expression and splicing in alcoholic liver disease.Sci Rep2026https://conductscience.org/library/papers/42168268PubMed
41939890GPX2+ tumor cells recruit LGALS1+ B cells via CCL26-CCR3 axis to promote immunosuppression and tumor progression in hepatocellular carcinoma.Front Immunol2026https://conductscience.org/library/papers/41939890PubMed
41041545Global Changes in Gene Expression and Splicing in Alcoholic Liver Disease.Res Sq2025https://conductscience.org/library/papers/41041545PubMed
40944258Alcohol and Tea Consumption in Relation to Liver Cancer Risk by Diabetes Status: A Prospective Cohort Study of 0.5 Million Chinese Adults.Nutrients2025https://conductscience.org/library/papers/40944258PubMed
40783888Ubiquitous Environmental Exposures and Risk of Hepatocellular Carcinoma: A Narrative Review.Dig Dis Sci2026https://conductscience.org/library/papers/40783888PubMed
40721214Public health strategies for hepatocellular carcinoma: from risk factors to prevention and control.J Liver Cancer2025https://conductscience.org/library/papers/40721214PubMed
40655398The impact of diabetes and social, biologic and behavioral determinants of health on liver cancer risk.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40655398PubMed
40141002Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma.Exp Hematol Oncol2025https://conductscience.org/library/papers/40141002PubMed
39867264Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus.J Hepatocell Carcinoma2025https://conductscience.org/library/papers/39867264PubMed
39524465Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma.J Immunother Precis Oncol2024https://conductscience.org/library/papers/39524465PubMed
39362712Alcohol and Hepatocellular Carcinoma.Clin Liver Dis2024https://conductscience.org/library/papers/39362712PubMed
39301314Casual effects of type 1 diabetes mellitus on site-specific digestive cancers: a Mendelian randomisation analysis.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/39301314PubMed
39240221Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis.Cancer Epidemiol Biomarkers Prev2024https://conductscience.org/library/papers/39240221PubMed
39120631Hepatitis B virus infection and the risk of gynecologic cancers: a systematic review and meta-analysis.Discov Oncol2024https://conductscience.org/library/papers/39120631PubMed
38977823Investigating the causal association between obesity and risk of hepatocellular carcinoma and underlying mechanisms.Sci Rep2024https://conductscience.org/library/papers/38977823PubMed
38692395Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes.Gastroenterology2024https://conductscience.org/library/papers/38692395PubMed
38426692Immunological pathways in viral hepatitis-induced hepato-cellular carcinoma.Zhejiang Da Xue Xue Bao Yi Xue Ban2024https://conductscience.org/library/papers/38426692PubMed

See all 290 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12395331

GET https://conductscience.org/api/papers/v1/12395331/cited_by?page=2